The supplier of Fukera, Henry Meds, no longer offers submitted injections of maiden, but allowed patients to place mass orders before withdrawing them. He went forward and ordered vials of several months, but he doesn’t know what to do when he would end. “I am very nervous about what will happen,” he says. “I will keep every drop from each vial to make it stretch a little longer.” (From the publication Henry Meds offers novel and current patients ability A mass ban on 40 weeks of semaglutide injections. Henry Meds did not answer the request for comment.)
Jim Bertel, a 41-year-old who lives in Colorado and assigns Tirrzepatide for changing his life, was also able to supply his sophisticated GLP-1 drugs before his supplier stopped selling him. He is not sure what he will do when it ends this month, and spends time searching for Reddit and Facebook forums to find which Sophia companies still offer drug versions. “At the moment my plan is to take it from month to month,” he says. “Hopping from the supplier to the supplier.”
40 -year -old Jessie, who asked only her name to identify her, turned to the medical spa to get intensified medicines when she could not get consistent access through her insurance or basic healthcare supplier. Her supplier initially wrote her prescription for Wegova, but she says that it was “touch and go.” She was able to complement the sophisticated version with Med SPA when it was not available. But at the end of last year, Jessie received a letter from her insurance company with information that she would no longer include Wegova. Then her basic care supplier warned the recipe for slimming drugs, saying that they were too troublesome. She returned to Med Spa and was able to submit a semaglutide in April, but the object said that he could not guarantee that supply. He is now considering buying a drug from Mexico because he often travels to San Diego to work. “These are the same drugs, you don’t need a prescription and is cheaper,” he says. In Mexico, the Wegova brand You can buy for around $ 200 per month.
Overall insurance has helped to enhance the demand for sophisticated GLP-1 products. Despite the approval of Wegova and Zepbound for patients with a body weight index of 30 or more and 27 or more in patients with at least one weight-related ailment, some insurance plans require higher BMI or additional protection criteria-if they even include drugs for obesity. “The whole basic topic here is a mark and prejudice not to recognize obesity as a disease such as cancer and diabetes and everything else,” says Florencia Halperin, an endocrinologist and medical director in forms Health, an online medical slimming clinic, “for cancer, you would never have an employer who says,” we don’t discuss it. “
Amanda Bonello, founder and general director of the GLP-1 Collective, a non-profit organization aimed at helping patients in access to these drugs, is not surprised by the length to which patients go. Bonello, which herself has adopted the sophisticated GLP-1 products, says that in many patients she talked to, the impact of these drugs does not apply to the weight itself.